Bile duct and pancreatic diseases
Conditions
Interventions
Control group:Equal doses of normal saline
Lidocaine group:Lidocaine was given intravenously (1.0 mg/kg) and then continuously (2.0 mg/kg/h)
Sponsors
Shanghai Shuguang Hospital, University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with ASA grade III-IV, aged 65-80 years, BMI 18.5-23.99, Mallampati Airway Grade I-II.
Exclusion criteria
Exclusion criteria: Patients with previous history of hypoxemia (pulse Oxygenation < 90%), hypotension (systolic blood pressure <90 mmHg) , bradycardia (heart rate < 50 beats per minute) , hypertension (systolic blood pressure 170 mmHg, diastolic blood pressure <100 mmHg) , severe kidney or liver failure, pregnancy or lactation, allergy to lidocaine, atrioventricular block, epilepsy, and inability to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of sedation-related adverse events (SRAEs); | — |
Secondary
| Measure | Time frame |
|---|---|
| The dose of propofol;Wake-up time;visual analogue scale score of anesthesia resuscitation room;Doctor Satisfaction;Patient satisfaction;Lidocaine-related adverse events; | — |
Countries
China
Contacts
Public ContactGao Hao
Shanghai Shuguang Hospital, University of Traditional Chinese Medicine
Outcome results
None listed